Hengli Lu

489 total citations · 1 hit paper
13 papers, 358 citations indexed

About

Hengli Lu is a scholar working on Molecular Biology, Rheumatology and Biomedical Engineering. According to data from OpenAlex, Hengli Lu has authored 13 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Rheumatology and 4 papers in Biomedical Engineering. Recurrent topics in Hengli Lu's work include Extracellular vesicles in disease (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Hengli Lu is often cited by papers focused on Extracellular vesicles in disease (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Hengli Lu collaborates with scholars based in China. Hengli Lu's co-authors include Tianyang Xu, Kaiyuan Liu, Zihua Li, Yang Dong, Yu Chen, Huijing Xiang, Guodong Li, Yingying Jiang, Guodong Li and Wenwei Jiang and has published in prestigious journals such as Advanced Materials, ACS Nano and Biomaterials.

In The Last Decade

Hengli Lu

13 papers receiving 356 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radical-Scavenging and Subchondral Bone-Regenerating Nanomedicine for Osteoarthritis Treatment

2023 89 citations Hengli Lu, Kaiyuan Liu et al. ACS Nano profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hengli Lu China	10	152	145	69	61	55	13	358
Fubo Chen China	11	130 0.9×	95 0.7×	45 0.7×	65 1.1×	37 0.7×	24	328
Bide Tong China	11	154 1.0×	127 0.9×	36 0.5×	49 0.8×	25 0.5×	20	411
Yangmengfan Chen China	11	104 0.7×	169 1.2×	69 1.0×	28 0.5×	23 0.4×	17	352
Meghan Hill United States	7	194 1.3×	87 0.6×	86 1.2×	75 1.2×	30 0.5×	17	363
Fuxiao Wang China	11	226 1.5×	101 0.7×	23 0.3×	58 1.0×	31 0.6×	20	383
Zhongyi Gu China	8	129 0.8×	148 1.0×	148 2.1×	62 1.0×	29 0.5×	9	559
Ming Jia China	9	228 1.5×	127 0.9×	60 0.9×	42 0.7×	103 1.9×	12	472
Shuanglin Peng China	12	256 1.7×	139 1.0×	59 0.9×	64 1.0×	29 0.5×	22	453
Long Bai China	10	223 1.5×	107 0.7×	27 0.4×	64 1.0×	19 0.3×	25	383
Qiujun Liang China	10	307 2.0×	269 1.9×	76 1.1×	58 1.0×	71 1.3×	10	554

Countries citing papers authored by Hengli Lu

Since Specialization

Citations

This map shows the geographic impact of Hengli Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengli Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengli Lu more than expected).

Fields of papers citing papers by Hengli Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengli Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengli Lu. The network helps show where Hengli Lu may publish in the future.

Co-authorship network of co-authors of Hengli Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hengli Lu. A scholar is included among the top collaborators of Hengli Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengli Lu. Hengli Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Zhang, Yiwei, Zihua Li, Hengli Lu, et al.. (2025). Pan-cancer analysis uncovered the prognostic and therapeutic value of disulfidptosis. npj Precision Oncology. 9(1). 50–50. 1 indexed citations

Liu, Kaiyuan, Pengfei Zan, Zihua Li, et al.. (2024). Engineering Bimetallic Polyphenol for Mild Photothermal Osteosarcoma Therapy and Immune Microenvironment Remodeling by Activating Pyroptosis and cGAS‐STING Pathway. Advanced Healthcare Materials. 13(22). e2400623–e2400623. 10 indexed citations

Wang, Sen, Dong Yang, Hengli Lu, et al.. (2024). The effect of Miya on skeletal muscle changes by regulating gut microbiota in rats with osteoarthritis through AMPK pathway. BMC Musculoskeletal Disorders. 25(1). 1081–1081. 2 indexed citations

Li, Zihua, Hengli Lu, Xiaoyi Ma, et al.. (2024). Microneedle‐Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K‐Akt‐mTOR Pathway. Advanced Science. 11(42). e2406942–e2406942. 26 indexed citations

Lu, Hengli, Zihua Li, Yuxin Liao, et al.. (2024). Photothermal Catalytic Reduction and Bone Tissue Engineering Towards a Three‐in‐One Therapy Strategy for Osteosarcoma. Advanced Materials. 36(40). e2408016–e2408016. 16 indexed citations

Li, Zihua, Hengli Lu, Jiyang Lv, et al.. (2024). Blocking CXCR4–CARM1–YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis. Cancer Science. 115(10). 3305–3319. 4 indexed citations

Zhang, Yiwei, et al.. (2023). Physical activity modifies the association of the composite dietary antioxidant index with all-cause mortality in the US osteoarthritis population. Frontiers in Public Health. 11. 1297245–1297245. 9 indexed citations

Liu, Kaiyuan, Li Zhang, Hengli Lu, et al.. (2023). Enhanced mild-temperature photothermal therapy by pyroptosis-boosted ATP deprivation with biodegradable nanoformulation. Journal of Nanobiotechnology. 21(1). 64–64. 43 indexed citations

Lu, Hengli, Kaiyuan Liu, Zihua Li, et al.. (2023). Radical-Scavenging and Subchondral Bone-Regenerating Nanomedicine for Osteoarthritis Treatment. ACS Nano. 17(6). 6131–6146. 89 indexed citations breakdown →

10.

Liu, Kaiyuan, Yuxin Liao, Zifei Zhou, et al.. (2022). Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunity. Biomaterials. 282. 121383–121383. 70 indexed citations

11.

Wang, Wenhan, Hengli Lu, Lei Liang, et al.. (2022). Charge transfer of ZnTPP/C60 cocrystal-hybridized bioimplants satisfies osteosarcoma eradication with antitumoral, antibacterial and osteogenic performances. Nano Today. 46. 101562–101562. 11 indexed citations

12.

Xu, Tianyang, Yang Dong, Kaiyuan Liu, et al.. (2021). Efficacy and safety of a self-developed home-based enhanced knee flexion exercise program compared with standard supervised physiotherapy to improve mobility and quality of life after total knee arthroplasty: a randomized control study. Journal of Orthopaedic Surgery and Research. 16(1). 382–382. 15 indexed citations

13.

Dong, Yang, Kaiyuan Liu, Lin Fan, et al.. (2020). LncRNA RP11-361F15.2 promotes osteosarcoma tumorigenesis by inhibiting M2-Like polarization of tumor-associated macrophages of CPEB4. Cancer Letters. 473. 33–49. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact